Location History:
- Saint Martin d'Hères, FR (2022)
- Saint Martin d'Heres, FR (2023)
Company Filing History:
2 out of 5,081 
1 out of 222 
Years Active: 2022-2023
Title: **Innovative Contributions of Tamiris Figueiredo**
Introduction
Tamiris Figueiredo is an accomplished inventor based in Saint Martin d'Hères, France. With two notable patents to his name, he has made significant contributions in the field of biomaterials, particularly through his innovative work on glycosaminoglycans.
Latest Patents
Figueiredo’s latest patents focus on a novel method of crosslinking glycosaminoglycans. His innovative hydrogel, composed of crosslinked glycosaminoglycans—including hyaluronic acid, chondroitin, and chondroitin sulfate—features reversible linkages facilitated by boronic acid or boroxole derivatives. This advancement allows for new applications and benefits, enhancing the functionality of biocompatible materials. The process involves the formation of an alkoxyboronate ester anion, created between a diol portion of a diol-functional moiety grafted to a first glycosaminoglycan and a boronate hemiester grafted to a second glycosaminoglycan.
Career Highlights
Throughout his career, Tamiris Figueiredo has been associated with prestigious institutions. He has worked with the Centre National De La Recherche Scientifique and Galderma Research & Development, where he applied his expertise in the development of advanced biomaterials. His work has led to improvements in various biomedical applications, showcasing his dedication to innovation in science.
Collaborations
Figueiredo has collaborated with notable researchers in his field, including Rachel Auzely-Velty and Laura Jing Jing. These partnerships have furthered his work and contributed to the advancements in biochemistry and materials science, fostering a collaborative environment that emphasizes innovation and research.
Conclusion
Tamiris Figueiredo stands out as a pioneering inventor whose work on glycosaminoglycans presents exciting new possibilities in biomaterials. With his impressive patent portfolio and collaborative spirit, he continues to drive innovation forward, positively impacting the fields of biotechnology and medicine.